共查询到20条相似文献，搜索用时 218 毫秒
1.
利用酒石酸泰乐菌素在试管中对鸡毒支原体进行了抑菌试验和在鸡体内对人工诱发的鸡毒支原体病进行了治疗试验。结果表明 :酒石酸泰乐菌素能有效地抑制试管中鸡毒支原体的生长繁殖。当饮水中药物浓度达到250mg/L以上时 ,能提高感染鸡的成活率 ;当饮水中药物浓度达到500mg/L以上时能降低气囊损伤 ,对提高鸡体增重也有一定的作用 ;当浓度达到1000mg/L时 ,则部分治疗的感染鸡体内检测不到鸡毒支原体抗体。国产酒石酸泰乐菌素作用与进口酒石酸泰乐菌素相接近 相似文献
2.
3.
双原清对猪支原体病的治疗试验 总被引：1，自引：0，他引：1
以人工诱发猪支原体感染为模型,以酒石酸泰乐菌素为对照药物,评价了进口泰妙菌素与双原清（国产泰妙菌素）的疗效。按照每吨饲料中分别添加进口泰妙菌素65ppm和150ppm金霉素,双原清65ppm和150ppm金霉素,酒石酸泰乐菌素150ppm和150ppm金霉素,150ppm金霉素4组进行连续30d添加。试验结果表明双原清可明显控制猪支原体病,提高育成猪的增重,改善料肉比,同时双原清（国产泰妙菌素）与进口泰妙菌素在使用效果中无明显差异。 相似文献
4.
泰乐菌素是由弗氏链霉菌产生的一种大环内酯类动物专用抗生素，主要有酒石酸泰乐菌素和磷酸泰乐菌素，具有抗菌谱广、临床应用范围广、促生长作用明显、毒副作用小、残留量低等特点。在兽医临床上，泰乐菌素对支原体有特效，是治疗畜禽支原体疾病的首选药物。在畜禽饲养业，泰乐菌素广泛应用于鸡、猪、牛的饲料中，能明显促进畜禽生长，提高生长速率，缩短饲养周期，提高饲料利用率和经济效益。1． 泰乐菌素的使用方法（图1） 2． 使用泰乐菌素的注意事项 1．配伍禁忌 泰乐菌素一般不与杆菌肽锌、北里霉素、维吉尼亚霉素、黄霉素、喹乙醇、… 相似文献
5.
泰乐菌素对鸡毒支原体在体内外的抑菌治疗试验 总被引：3，自引：3，他引：0
泰乐菌素对鸡毒支原体在体内外的抑菌治疗试验宁宜宝中国兽药监察所，北京１０００８１收稿日期：１９９６－０４－１１利用磷酸泰乐菌素和酒石酸泰乐菌素在试管中和鸡体内分别对鸡毒支原体进行了抑菌和治疗试验，结果表明：这两种药物在试管中都能有效地抑制鸡毒支原体的... 相似文献
6.
替米考星与泰乐菌素对畜禽常见病原菌抑菌作用比较 总被引：1，自引：0，他引：1
采用试管2倍稀释法对国产替米考星与泰乐菌素进行了畜禽常见的20种病原菌体外抑菌活性比较试验。结果表明,替米考星和泰乐菌素具有类似的抗菌谱,二者对革兰氏阳性菌均有良好的抑制作用。对革兰氏阴性菌二者除对禽多杀性巴氏杆菌、红斑丹毒丝菌、胸膜肺炎放线杆菌和鸡毒支原体均有较强的抑菌效果外,对其他菌则表现为抑菌效果较弱或抗药性。替米考星对部分病原菌如鸡白痢沙门菌、鼠伤寒沙门菌、肺炎克雷伯菌抑菌效果明显强于酒石酸泰乐菌素。总体来看,替米考星对畜禽常见病原菌的抑菌活性比泰乐菌素要强一些。 相似文献
7.
利用酒石酸泰乐菌素在试管中对鸡毒支原体进行了抑菌试验和在鸡体内对人工诱发的鸡毒支原体病进行了治疗试验。结果表明,酒石酸泰乐菌素能有效地抑制试管中鸡毒支原体的生长繁殖。当饮水中药物浓达到２５０ｍｇ／Ｌ以上时,能提高感染鸡的成活率,当饮水中药物浓度达到５００ｍｇ／Ｌ以上时能降低气囊损伤,对提高鸡体增重也有一定的作用;当浓度达到１０００ｍｇ／Ｌ时,则部分治疗的感染鸡体内检测不到鸡毒支原体抗休画产酒石酸泰 相似文献
8.
正确安全使用泰乐菌素 总被引：1，自引：0，他引：1
泰乐菌素属于大环内酯类抗生素,抗菌谱与红霉素相仿.系由放线菌属弗氏链霉菌经发酵提取而得到的一种大环内酯类动物专用抗生素,有泰乐菌素碱、磷酸盐和酒石酸盐3种形态.磷酸泰乐菌素作为饲料添加剂,广泛用于猪的饲料中,可以缩短饲养周期,提高饲料报酬,有效防治呼吸道及消化道感染;酒石酸泰乐菌素,可防治支原体病. 相似文献
9.
10.
以人工诱发鸡毒支原体和大肠杆菌混合感染为模型,以酒石酸泰乐菌素为对照药物,评价了延胡索酸泰妙菌素的疗效.按每1 L水中分别加入312.5、468、625 mg延胡索酸泰妙菌素及500 mg酒石酸泰乐菌素的用量给病鸡饮水给药,连用5 d.试验表明,用药组的成活率、日增重、料肉比、气囊损伤度与感染对照组比较差异极显著(P＜0.01);延胡索酸泰妙菌素大剂量组日增重与小剂量组比较差异显著(P＜0.05),与其他各用药组比较差异极显著(P＜0.01),料肉比与其他各用药组比较差异极显著(P＜0.01);酒石酸泰乐菌素组的料肉比与延胡索酸泰妙菌素小剂量组比较差异不显著(P＞0.05);而与其他各组比较差异极显著(P＜0.01).数据分析表明,延胡索酸泰妙菌素大剂量组能有效地降低气囊损伤度,提高饲料转化率. 相似文献
11.
12.
鹅巴氏杆菌病病原分离鉴定及中西药联用抑菌试验 总被引：1，自引：0，他引：1
应用常规分离鉴定技术,对湛江市某养鹅场的病鹅进行病原分离与鉴定,采用水提法制备中药药液,通过试管二倍稀释法测定各中药药液和抗菌药对病原菌的最小抑菌浓度（MIC）及最小杀菌浓度（MBC）,同时测定中药与西药联用对病原菌的体外抑菌效果。结果表明,分离的病原菌符合巴氏杆菌的生化特性;中药与西药联用抑菌和杀菌能力均大于或等于单药,恩诺沙星与五倍子联用,恩诺沙星用量为单药的1/4、五倍子用量为单药的1/8即可抑制巴氏杆菌;酒石酸泰乐菌素与夏枯草联用,酒石酸泰乐菌素用量为单药的1/16、夏枯草用量为单药的1/4即可抑菌;酒石酸泰乐菌素与五倍子联合,酒石酸泰乐菌素用量为单药的1/4即能杀菌。 相似文献
13.
酒石酸泰乐菌素联合阿莫西林钠缩小猪链球菌耐药突变选择窗的研究 总被引：2，自引：0，他引：2
为了使临床合理使用抗菌药物,防止细菌耐药性的产生提供理论依据。本研究探讨了在体外初步联合用药缩小猪链球菌(S.suis)的耐药突变选择窗(MSW)。应用肉汤法富集1010CFU/mL细菌,琼脂平板二倍稀释法分别测定酒石酸泰乐菌素(TLST)、阿莫西林(Amoxil)钠及两药联用后对S.suis分离株D10的防突变浓度(MPC)和MSW。TLST、Amoxil钠单药和两药联用对S.suis分离株D10的MSW分别为9.71、5.16和2.81。TLST和Amoxil钠联合用药使TLST对D10的MSW缩小3.5倍;TLST和Amoxil钠联合用药使Amoxil钠对D10的MSW缩小1.8倍。TLST和Amoxil钠联合用药可缩小各自单药对S.suis分离株D10的MSW。 相似文献
14.
HPLC法测定复方制剂中的酒石酸泰乐菌素 总被引：1，自引：0，他引：1
采用Kromasil C18色谱柱,甲醇-水(80:20)为流动相,检测波长为290nm,以HPLC外标法测定复方制剂中酒石酸泰乐菌素的含量。该法分离度大,被测组分的线性关系良好(r=0.9999),平均回收率100.0%,重复进样相对标准偏差0.16%。 相似文献
15.
Tylosin tartrate, administered in the drinking water at a concentration of 0.55 g/litre for the first three days after hatching, was highly effective in controlling the adverse consequences of a Mycoplasma gallisepticum infection, established by air sac injection at one day of age, in turkey poults. Tylosin was ineffective in controlling M meleagridis infections established in embryo or at one day of age when administered in the drinking water of poults. Both mycoplasma isolates used were inhibited in vitro by a tylosin concentration of 0.1 mug/ml. 相似文献
16.
The anti-mycoplasma effects of the ionophores (lasalocid sodium, monensin and nigericin) were compared with that of tylosin tartrate and tiamulin in vitro. Forty-four strains representing 14 avian and 10 mammalian Mycoplasma species and serotypes and 5 Acholeplasma species were tested. The ionophores showed average minimal inhibitory concentration (MIC) values between 3.65 and 4.93 micrograms ml-1 for all strains, the MIC values for glucose-fermenting strains were between 2.26 and 3.75 micrograms ml-1, significantly lower than for arginine-hydrolysing strains (9.27-13.12 micrograms ml-1). These values were significantly higher than those obtained with tylosin tartrate (0.45 micrograms ml-1) or tiamulin (0.13 micrograms ml-1). The ionophores were more efficacious against acholeplasmas (0.06-0.25 micrograms ml-1) than against mycoplasmas. 相似文献
17.
The objective of this study was to determine the in vitro minimum inhibitory concentration (MIC) of antimicrobials against 10 isolates of Lawsonia intracellularis, the etiological agent of proliferative enteropathy (PE). Antimicrobials tested included carbadox, chlortetracycline, lincomycin, tiamulin, tylosin and valnemulin. The MIC of each antimicrobial against L. intracellularis was determined using a tissue culture system and was identified as the lowest concentration that inhibited 99% of L. intracellularis growth, as compared to the antimicrobial-free control. Each antimicrobial concentration was evaluated for both intracellular and extracellular activity against L. intracellularis, an obligately intracellular bacterium. When tested for intracellular activity, carbadox, tiamulin, and valnemulin were the most active antimicrobials with MICs of < or =0.5microg/ml. Tylosin (MICs ranging from 0.25 to 32microg/ml) and chlortetracycline (MICs ranging from 0.125 to 64microg/ml) showed intermediate activities and lincomycin (MICs ranging from 8 to >128mIcog/ml) showed the least activity. When tested for extracellular activity, valnemulin (MICs ranging from 0.125 to 4microg/ml) was the most active against most L. intracellularis isolates. Chlortetracycline (MICs ranging from 16 to 64microg/ml), tylosin (MICs ranging from 1 to >128microg/ml), and tiamulin (MICs ranging from 1 to 32microg/ml) showed intermediate activities. Lincomycin (MICs ranging from 32 to >128microg/ml) showed the least activity. Our in vitro results showed that each L. intracellularis isolate had a different antimicrobial sensitivity pattern and these data can be utilized as an in vitro guideline for the further antimicrobial evaluation of field L. intracellularis isolates. 相似文献
18.
Minimum inhibitory concentrations (MICs) were determined in vitro for 7 antibiotics (aivlosin, enrofloxacine, tylosin, tiamulin, kitasamycin, chlortetracycline, and oxytetracycline) against eight recent local Argentinean isolates and two standard strains of Mycoplasma synoviae. Aivlosin (3-acetyl-4"-isovaleryl tylosin tartrate), tylosin, and tiamulin showed the lowest MICs with MIC90s of 0.006, 0.012, and 0.05 microg/ml, respectively. Except one strain that showed resistant values to chlortetracycline (> or = 12.5 microg/ml), all the analyzed strains were susceptible in different degrees to all the antibiotics tested. In this study, the improved activity of the tylosin-derived drug, aivlosin, was confirmed because it showed, in most strains, MIC values half those for tylosin. 相似文献
19.
Ziv G 《The Veterinary quarterly》1980,2(4):206-210
Summary The minimal inhibitory concentrations (M1C) of tiamulin and tylosin for mycoplasma. Gram-positive, and Gram-negative micro-organisms isolated from chickens were determinated by the agar dilution method. Median M1C values for tiamulin against Mycoplasma gallisepticum (0.05 μg/ml) and Mycoplasma synoviae (0.10 μg/ml) were 2 to 4 times lower than the corresponding values for tylosin. Tiamulin was also slightly more effective in vitro in inhibiting Escherichia coli, Pasteurella multocida, and beta-haemolytic streptococci than was tylosin. Groups of chicken were offered tiamulin medicated drinking water at rates of 125 and 250 mg/litre for 48 hours. Average serum tiamulin concentrations were 0.38 and 0.78 μg/ml, respectively. When tylosin tartrate was added to the drinking water at 500 and 700 mg/litre, average serum drug levels were 0.12 and 0.17 μg/ml, respectively. Tiamulin was 45% bound in chicken serum, as against 30% serum protein binding or tylosin. Correlations were made between free (non protein bound) serum drug levels and the MIC values of the two drugs. Such comparisons suggest that when tiamulin is given in the drinking water at rates of 125 to 250 mg/litre, better antimycoplasmal activity is to be expected in vivo than by giving tylosin tartrate in the drinking water at 500 to 700 mg/litre. Based on these data, no clinical efficacy of these dose rates can be expected in flocks infected by gram-negative microorganisms such as E. coli or P. multocida. The tylosin tartrate rate of 500 to 700 mg/litre, may be clinical ineffective the treatment of Staphylococcus aureus infections. 相似文献
20.
Hannan PC 《Veterinary research》2000,31(4):373-395
The absence of standardised procedures for minimum inhibitory concentration (MIC) testing of antimicrobial agents against veterinary mycoplasma and ureaplasma species (Mollicutes) has made it difficult to compare results originating from different laboratories. This report, prepared on behalf of the International Research Programme on Comparative Mycoplasmology (IRPCM), offers guidelines and recommendations for veterinary MIC testing of these organisms in an effort to rectify this problem. The subjects discussed include suitable media for broth and agar MIC assays, storage and preparation of antimicrobial agents, standardisation of mycoplasma inocula for MIC tests, validation of equipment, incubation conditions, and determination of MIC end points. A standard medium for all veterinary mycoplasma MIC tests cannot currently be recommended, owing to the diversity of nutritional requirements of different mycoplasma species. Instead mycoplasma broths or agars giving optimal growth of specific mycoplasmas or ureaplasmas are recommended, as suboptimal growth may lead to falsely low MIC results. The importance of using standardised mycoplasma inocula, for assays using either solid or liquid media is stressed. The growth phase may be less important as lag phase and logarithmic phase cultures of Mycoplasma gallisepticum, M. synoviae, M. bovis and M. hyopneumoniae have given very similar results in liquid MIC assays. The liquid method of Tanner and Wu and the agar method described by Hannan et al. are compared and described in detail. Methods for calculating MIC50s and MIC90s are described and the interpretation of results discussed. Methods for assessing mycoplasmacidal (MMC) activity of antimicrobial agents are also described. Adoption of these guidelines should lead to more consistent MIC results being obtained between laboratories. 相似文献